Nina Nacke
5 Papers
Nina Nacke is an academic researcher. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
Michael Oertel,Dominik Hering,Nina Nacke,Christopher Kittel,Kai Kröger,Jan Kriz,Michael Fuchs,Christian Baues,Dirk Vordermark,Rita Engenhart-Cabillic,Klaus Herfarth,Peter Lukas,Heinz Schmidberger,Simone Marnitz,Peter Borchmann,Andreas Engert,Uwe Haverkamp,Hans Theodor Eich +17 more
TL;DR: In this article , the authors evaluated the effect of consolidative involved-node radiotherapy (INRT) for patients with PET-positive after chemotherapy and enabled a comparison between INRT and involved-field (IF)RT.
5
P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group
Michael Oertel,Dominik Hering,Nina Nacke,Christopher Kittel,Kai Kröger,Jan Kriz,Michael Fuchs,Christian Baues,Dirk Vordermark,Rita Engenhart-Cabillic,Klaus Herfarth,Peter Lukas,Heinz Schmidberger,Simone Marnitz,Peter Borchmann,Andreas Engert,Uwe Haverkamp,Hans Theodor Eich +17 more
P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
Michael Oertel,Dominik Hering,Christopher Kittel,Nina Nacke,Kai Kröger,Jan Kriz,Michael Fuchs,Christian Baues,Dirk Vordermark,Rita Engenhart-Cabillic,Klaus Herfarth,Peter Lukas,Heinz Schmidberger,Simone Marnitz,Peter Borchmann,Uwe Haverkamp,Andreas Engert,Hans Theodor Eich +17 more
Quality Analysis of Radiation Therapy for Hodgkin Lymphoma in the HD 16/17 Trials: A Final Report By the Reference Radiation Oncology Panel of the German Hodgkin Study Group.
M. Oertel,D. Hering,Christopher Kittel,Nina Nacke,Kai Kröger,J T Kriz,M. Fuchs,Christian Baues,D. Vordermark,R. Engenhart-Cabillic,K.K. Herfarth,P. Lukas,H. Schmidberger,S. Marnitz-Schulze,Peter Borchmann,A. Engert,Uwe Haverkamp,H. T. Eich +17 more
TL;DR: Quality of RT in the planning and treatment of HL has improved significantly with the latest GHSG study generation and the size of the planning target volume decreased significantly with INRT compared to IFRT.
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial
M. Oertel,Marita Ziepert,Fabian Frontzek,Nina Nacke,Bettina Altmann,Maike Nickelsen,Bertram Glass,Viola Poeschel,C. Ruebe,G. Lenz,Norbert Schmitz,H. T. Eich +11 more
TL;DR: This phase 3 trial found that consolidative radiotherapy significantly improved 10-year event-free survival, progression-free survival, and overall survival in young patients with bulky aggressive B-cell lymphoma, without increasing secondary malignancies.